Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

option care health inc - OPCH

OPCH

Close Chg Chg %
28.41 0.08 0.28%

Pre-Market

28.49

+0.08 (0.28%)

Volume: 1.25M

Last Updated:

Mar 25, 2026, 4:00 PM EDT

Trade Now

Company Overview: option care health inc - OPCH

OPCH Key Data

Open

$28.70

 Day Range

28.33 - 28.79

52 Week Range

24.24 - 36.79

 Market Cap

$4.44B

Shares Outstanding

156.45M

 Public Float

153.94M

Beta

0.85

 Rev. Per Employee

N/A

P/E Ratio

22.36

 EPS

$1.28

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.98M

  

OPCH Performance

1 Week
 
 1.17%
 
1 Month
 
 -12.23%
 
3 Months
 
 -12.55%
 
1 Year
 
 -17.97%
 
5 Years
 
 57.66%
 

OPCH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 13
Full Ratings ➔

About option care health inc - OPCH

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

OPCH At a Glance

Option Care Health, Inc.
3000 Lakeside Drive
Bannockburn, Illinois 60015
Phone 1-312-940-2443 Revenue 5.65B
Industry Medical/Nursing Services Net Income 207.59M
Sector Health Services 2025 Sales Growth 13.031%
Fiscal Year-end 12 / 2026 Employees 6,528
View SEC Filings

OPCH Valuation

P/E Current 22.358
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 25.073
Price to Sales Ratio 0.921
Price to Book Ratio 3.768
Price to Cash Flow Ratio 20.14
Enterprise Value to EBITDA 15.285
Enterprise Value to Sales 1.105
Total Debt to Enterprise Value 0.204

OPCH Efficiency

Revenue/Employee 865,428.768
Income Per Employee 31,799.173
Receivables Turnover 11.044
Total Asset Turnover 1.596

OPCH Liquidity

Current Ratio 1.525
Quick Ratio 0.957
Cash Ratio 0.28

OPCH Profitability

Gross Margin 18.061
Operating Margin 5.981
Pretax Margin 5.008
Net Margin 3.674
Return on Assets 5.864
Return on Equity 15.204
Return on Total Capital 7.985
Return on Invested Capital 8.042

OPCH Capital Structure

Total Debt to Total Equity 96.001
Total Debt to Total Capital 48.98
Total Debt to Total Assets 35.825
Long-Term Debt to Equity 93.68
Long-Term Debt to Total Capital 47.796
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Option Care Health Inc - OPCH

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
3.94B 4.30B 5.00B 5.65B
Sales Growth
+14.72% +9.06% +16.17% +13.03%
Cost of Goods Sold (COGS) incl D&A
3.14B 3.38B 4.05B 4.63B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
85.15M 62.20M 63.50M 70.69M
Depreciation
51.96M 27.82M 29.09M 33.76M
Amortization of Intangibles
33.19M 34.38M 34.41M 36.93M
COGS Growth
+15.29% +7.71% +19.70% +14.41%
Gross Income
806.35M 922.02M 952.08M 1.02B
Gross Income Growth
+12.53% +14.34% +3.26% +7.17%
Gross Profit Margin
+20.44% +21.43% +19.05% +18.06%
2022 2023 2024 2025 5-year trend
SG&A Expense
566.12M 607.43M 630.25M 682.45M
Research & Development
- - - -
-
Other SG&A
566.12M 607.43M 630.25M 682.45M
SGA Growth
+7.69% +7.30% +3.76% +8.28%
Other Operating Expense
- - - -
-
Unusual Expense
(1.09M) (52.97M) (11.15M) (3.89M)
EBIT after Unusual Expense
241.32M 367.57M 332.98M 341.80M
Non Operating Income/Expense
19.34M 53.40M 11.17M 4.30M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
5.13M 5.53M 5.96M 7.41M
Interest Expense
54.90M 62.22M 60.56M 63.20M
Interest Expense Growth
-1.02% +13.35% -2.68% +4.36%
Gross Interest Expense
54.90M 62.22M 60.56M 63.20M
Interest Capitalized
- - - -
-
Pretax Income
205.77M 358.74M 283.60M 282.90M
Pretax Income Growth
+76.63% +74.34% -20.95% -0.25%
Pretax Margin
+5.22% +8.34% +5.67% +5.01%
Income Tax
55.21M 91.65M 71.78M 75.31M
Income Tax - Current - Domestic
13.29M 76.73M 57.84M 64.60M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
41.93M 14.93M 13.94M 10.71M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
5.13M 5.53M 5.96M 7.41M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
150.56M 267.09M 211.82M 207.59M
Minority Interest Expense
- - - -
-
Net Income
150.56M 267.09M 211.82M 207.59M
Net Income Growth
+7.62% +77.40% -20.69% -2.00%
Net Margin Growth
+3.82% +6.21% +4.24% +3.67%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
150.56M 267.09M 211.82M 207.59M
Preferred Dividends
- - - -
-
Net Income Available to Common
150.56M 267.09M 211.82M 207.59M
EPS (Basic)
0.8313 1.4924 1.2346 1.2806
EPS (Basic) Growth
+6.88% +79.53% -17.27% +3.73%
Basic Shares Outstanding
181.10M 178.97M 171.57M 162.10M
EPS (Diluted)
0.8269 1.4808 1.2255 1.2707
EPS (Diluted) Growth
+7.11% +79.08% -17.24% +3.69%
Diluted Shares Outstanding
182.07M 180.38M 172.84M 163.37M
EBITDA
325.38M 376.80M 385.33M 408.60M
EBITDA Growth
+18.40% +15.80% +2.27% +6.04%
EBITDA Margin
+8.25% +8.76% +7.71% +7.23%

Snapshot

Average Recommendation BUY Average Target Price 40.091
Number of Ratings 13 Current Quarters Estimate 0.378
FY Report Date 03 / 2026 Current Year's Estimate 1.865
Last Quarter’s Earnings 0.46 Median PE on CY Estimate N/A
Year Ago Earnings 1.72 Next Fiscal Year Estimate 2.131
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12 12 12 12
Mean Estimate 0.38 0.46 1.87 2.13
High Estimates 0.41 0.47 1.90 2.22
Low Estimate 0.35 0.43 1.83 2.04
Coefficient of Variance 4.92 3.02 1.22 2.26

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 11 12
OVERWEIGHT 1 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Option Care Health Inc - OPCH

Date Name Shares Transaction Value
Feb 20, 2026 John C. Rademacher Chief Executive Officer; Director 831,057 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Collin G. Smyser GC & Corporate Secretary 94,215 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Meenal A. Sethna Chief Financial Officer 82,112 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Michael Bavaro Chief Human Resources Officer 44,423 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $35.24 per share 1,565,466.52
Feb 20, 2026 Michael Bavaro Chief Human Resources Officer 54,002 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Luke Whitworth Chief Operating Officer 171,815 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $35.24 per share 6,054,760.60
Feb 20, 2026 Luke Whitworth Chief Operating Officer 202,238 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Christopher Grashoff Chief Growth Officer 35,880 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $35.24 per share 1,264,411.20
Feb 20, 2026 Christopher Grashoff Chief Growth Officer 48,558 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Femi Adewunmi Chief Medical Officer 28,337 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Nicole Maggio Chief Accounting Officer 26,229 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $35.24 per share 924,309.96
Feb 20, 2026 Nicole Maggio Chief Accounting Officer 30,455 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Option Care Health Inc in the News